Yellow fever vaccine attenuation revealed: Loss of diversity

Journal of Infectious Diseases

Volumn 209, Issue 3, 2014, Pages 318-320

  Tangy, Frédéric ^a   Desprès, Philippe ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

live attenuated vaccine; quasispecies.; Yellow fever virus

Indexed keywords

FRENCH NEUROTROPIC VACCINE; LIVE VACCINE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS RNA; YELLOW FEVER VACCINE;

DRUG SAFETY; ENDEMIC DISEASE; GENE MUTATION; GENETIC VARIABILITY; HEMORRHAGIC SHOCK; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; NEUROLOGIC DISEASE; NONHUMAN; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; VACCINATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE; WORLD HEALTH ORGANIZATION; YELLOW FEVER; YELLOW FEVER FLAVIVIRUS;

LIVE ATTENUATED VACCINE; QUASISPECIES.; YELLOW FEVER VIRUS;

GENOME, VIRAL; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; POLYMORPHISM, GENETIC; RNA, VIRAL; YELLOW FEVER VACCINE; YELLOW FEVER VIRUS;

EID: 84892650329     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit551     Document Type: Note

References (7)

1. Beck A, Tesh RB, Wood TG, Widen SG, Ryman KD, Barrett ADT. Comparison of live attenuated yellow fever vaccine 17D-204 strain to its virulent parental strain Asibi by deep sequencing. J Infect Dis 2013.
2. Theiler M, Smith HH. The effect of prolonged cultivation in vitro upon the pathogenicity of yellow fever virus. J Exp Med 1937; 65: 767-86.
3. Stokes A, Bauer JH, Hudson NP. The transmission of yellow fever to Macacus rhesus. 1928. Rev Med Virol. 2001; 11:141-8.
4. Monath T. Review of the risks and benefits of yellow fever vaccination including some new analyses. Expert Rev Vaccines 2012; 11:427-48.
5. Querec TD, Akondy RS, Lee EK, et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 2009; 10:116-25.
6. Vignuzzi M, Stone JK, Arnold JJ, Cameron CEAndino R. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 2006; 439:344-8.
7. Pulendran B,Miller J, Querec TD, et al. Case of yellow fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes. J Infect Dis 2008; 198:500-7.